GlassScriptPhysician profile
Mary Ward
NPI 1588183156
$2,092.27
in general payments reported to CMS, 2019-2025
20 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.44 · 2022: $114 · 2023: $1,454 · 2024: $287 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021 · Travel and Lodging: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.17 |
| Travel and Lodging | $916.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,204.38 | 2023 | Axonics |
| Endo Pharmaceuticals INC. | $184.28 | 2021-2024 | Xiaflex |
| Endo USA, INC. | $109.75 | 2024-2025 | Xiaflex |
| Glaxosmithkline, LLC. | $79.64 | 2024 | Zejula, Ojjaara |
| Novartis Pharmaceuticals Corporation | $62.58 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $59.90 | 2022-2024 | |
| Lilly USA, LLC | $48.11 | 2023-2024 | Mounjaro, Verzenio, Retevmo |
| Bayer Healthcare Pharmaceuticals INC. | $47.61 | 2023 | |
| Astellas Pharma US INC | $40.55 | 2023-2025 | Xtandi |
| Teva Pharmaceuticals USA, INC. | $37.42 | 2024-2025 | Uzedy |
| 180 Medical, INC. | $33.56 | 2023-2025 | |
| Axsome Therapeutics, INC. | $30.14 | 2025 | Auvelity |
| Jazz Pharmaceuticals INC. | $28.53 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $26.84 | 2024 | Libtayo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.78 | 2025 | Caplyta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $18.51 | 2023 | Nuzyra |
| Baxter Healthcare | $15.80 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Corcept Therapeutics | $13.98 | 2022 | |
| Coloplast Corp | $13.25 | 2021 | |
| Urovant Sciences INC | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.